Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.26
Delayed Data
As of Aug 23
 -0.31 / -6.78%
Today’s Change
1.29
Today|||52-Week Range
5.03
+167.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues66.1M15.0M0.000.00
 
 
 
Depreciation And Amortization694.0K955.0K1.1M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-----1.1M-1.2M
 
 
 
General Expenses81.2M79.3M88.3M73.1M
 
 
 
 
 
Research And Development57.2M59.6M64.9M50.4M
 
 
 
 
 
Total Operating Expenses81.9M80.3M89.4M74.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.7M-65.3M-89.4M-74.2M
 
 
 
 
 
Extraordinary Credit8.9M0.000.000.00
 
 
Extraordinary Charge0.000.000.00-1.9M
 
 
Interest Expense On Debt55.0K68.0K50.0K36.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-62.1M-85.1M-70.5M
 
 
 
 
 
Income Taxes-640.0K-411.0K-135.0K-232.0K
 
 
 
 
 
Net Income-5.0M-61.7M-85.2M-70.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS125.6M136.7M137.2M138.4M
 
 
 
 
 
Shares To Calculate EPS Diluted125.6M136.7M137.2M138.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.45-$0.62-$0.51
 
 
 
 
 
EPS Diluted-$0.04-$0.45-$0.62-$0.51